Jon Faiz Kayyem

Jon Faiz Kayyem has an estimated net worth of $193 Million. This is based on reported shares across multiple companies, which include REPROS THERAPEUTICS INC., AEOLUS PHARMACEUTICALS, INC., BIODESIX INC, Inhibrx, Inc., GenMark Diagnostics, Inc., and Inhibrx Biosciences, Inc..

2024 was Jon Faiz Kayyem's most active year for acquiring shares with 22 total transactions. Jon Faiz Kayyem's most active month to acquire stocks was the month of November. 2014 was Jon Faiz Kayyem's most active year for disposing of shares, totalling 17 transactions. Jon Faiz Kayyem's most active month to dispose stocks was the month of February. 2008 saw Jon Faiz Kayyem paying a total of $14,921,273.17 for 2,223,180 shares, this is the most they've acquired in one year. In 2024 Jon Faiz Kayyem cashed out on 3,977,610 shares for a total of $98,229,030.00, their largest year based on trade value.